Frances Zhao

1.3k total citations · 1 hit paper
12 papers, 987 citations indexed

About

Frances Zhao is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Frances Zhao has authored 12 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Frances Zhao's work include Cancer, Hypoxia, and Metabolism (4 papers), Immune Cell Function and Interaction (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Frances Zhao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Immune Cell Function and Interaction (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Frances Zhao collaborates with scholars based in United States, Australia and Poland. Frances Zhao's co-authors include Mark K. Bennett, Jinfu Yang, Susan D. Demo, Mirna L.M. Rodriguez, Francesco Parlati, Julie Janes, Evan R. Lewis, Taotao Wang, Peter J. Shwonek and Bindu Goyal and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Frances Zhao

11 papers receiving 979 citations

Hit Papers

Antitumor Activity of the... 2014 2026 2018 2022 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances Zhao United States 7 680 653 182 134 103 12 987
Jinfu Yang United States 6 766 1.1× 661 1.0× 209 1.1× 133 1.0× 85 0.8× 12 1.1k
Guy J. Laidig United States 5 1.0k 1.5× 653 1.0× 347 1.9× 125 0.9× 109 1.1× 9 1.4k
Chiara Balestrieri Italy 11 738 1.1× 496 0.8× 253 1.4× 62 0.5× 153 1.5× 19 1.1k
Fumiko Axelrod United States 9 895 1.3× 568 0.9× 458 2.5× 75 0.6× 99 1.0× 24 1.4k
Timothy F. Stanton United States 3 661 1.0× 749 1.1× 178 1.0× 127 0.9× 86 0.8× 3 1000
Mirna L.M. Rodriguez United States 9 781 1.1× 756 1.2× 211 1.2× 166 1.2× 100 1.0× 16 1.1k
Martin F. Orth Germany 11 664 1.0× 478 0.7× 193 1.1× 46 0.3× 85 0.8× 13 940
Margaret E. Torrence United States 8 714 1.1× 509 0.8× 286 1.6× 67 0.5× 80 0.8× 13 1.0k
Songbo Qiu United States 15 483 0.7× 271 0.4× 362 2.0× 44 0.3× 105 1.0× 26 872
Cristovão M. Sousa United States 4 683 1.0× 605 0.9× 468 2.6× 72 0.5× 173 1.7× 4 1.2k

Countries citing papers authored by Frances Zhao

Since Specialization
Citations

This map shows the geographic impact of Frances Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Zhao more than expected).

Fields of papers citing papers by Frances Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Zhao. The network helps show where Frances Zhao may publish in the future.

Co-authorship network of co-authors of Frances Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Zhao. A scholar is included among the top collaborators of Frances Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Zhao. Frances Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhao, Frances, et al.. (2025). Comparative study of management strategies for immune checkpoint inhibitor‐induced inflammatory arthritis: rheumatologists versus oncologists. Internal Medicine Journal. 55(3). 426–434. 1 indexed citations
2.
Gross, Matt I., Susan D. Demo, Jennifer B. Dennison, et al.. (2014). Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 13(4). 890–901. 797 indexed citations breakdown →
3.
Satwani, Prakash, Aniket Saha, Frances Zhao, et al.. (2014). Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Cytotherapy. 16(10). 1431–1440. 25 indexed citations
4.
Parlati, Francesco, Susan D. Demo, Matthew Gross, et al.. (2014). Abstract 1416: CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies. Cancer Research. 74(19_Supplement). 1416–1416. 12 indexed citations
5.
Parlati, Francesco, Susan D. Demo, Julie Janes, et al.. (2013). Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances. Blood. 122(21). 4226–4226. 21 indexed citations
6.
Parlati, Francesco, Tania Chernov-Rogan, Susan D. Demo, et al.. (2013). Abstract 1877: Anti-tumor activity of novel, potent, selective and orally-bioavailable glutaminase inhibitors.. Cancer Research. 73(8_Supplement). 1877–1877.
7.
Yang, Jinfu, Zhengping Wang, Ying Fang, et al.. (2011). Pharmacokinetics, Pharmacodynamics, Metabolism, Distribution, and Excretion of Carfilzomib in Rats. Drug Metabolism and Disposition. 39(10). 1873–1882. 110 indexed citations
11.
Wolfenden, Richard & Frances Zhao. (2004). Lithium-Catalyzed Hydroxide Attack at the Carbon Atom of Methyl Phosphate. Journal of the American Chemical Society. 126(28). 8646–8647. 7 indexed citations
12.
Severin, Anatoly, Frances Zhao, Dalya R. Soond, et al.. (2000). Characterization of a Mycobacterium smegmatis Mutant That Is Simultaneously Resistant to d -Cycloserine and Vancomycin. Antimicrobial Agents and Chemotherapy. 44(6). 1701–1704. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026